AstraZeneca hit by copycat Nexium and strong dollar in Q1
April 24, 2015 at 02:19 AM EDT
LONDON, April 24 (Reuters) - AstraZeneca's sales fell by a slightly less-than-expected 6 percent in the first quarter, hit by the launch of generic copies of its popular stomach acid pill Nexium in the vital U.S. market and the strong dollar.
